FMP

FMP

Enter

LIXT - Lixte Biotechnology ...

photo-url-https://images.financialmodelingprep.com/symbol/LIXT.png

Lixte Biotechnology Holdings, Inc.

LIXT

NASDAQ

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. The company was founded in 2005 and is based in Pasadena, California.

2.33 USD

-0.055 (-2.37%)

Latest LIXT News

GlobeNewsWire

Aug 15, 2024

LIXTE Biotechnology Holdings to Present at Two Investor Conferences

-Company to Present August 20 at Investor Summit Summer 2024 Virtual Conference; and September 9-11 at H.C. Wainwright 26 th Annual Global Investment Conference-

Read More

Accesswire

Aug 14, 2024

Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event

NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.

Read More

PennyStocks

Feb 13, 2023

How to Sustainably Invest in Penny Stocks

Here's some tips for sustainably investing in penny stocks The post How to Sustainably Invest in Penny Stocks  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

InvestorPlace

Feb 8, 2023

Why Is Lixte Biotech (LIXT) Stock Down 29% Today?

Lixte Biotech (NASDAQ: LIXT ) stock is dropping on Wednesday but it's not due to any negative news from the drug discovery company. Instead, it's the result of shares retreating after a massive rally on Wednesday.

Read More

PennyStocks

Feb 8, 2023

Can Trading Penny Stocks Be a Full Time Job?

Are penny stocks able to provide full time income? The post Can Trading Penny Stocks Be a Full Time Job?

Read More

Accesswire

Nov 30, 2022

LIXTE Biotechnology Holdings to Present at Planet MicroCap Showcase: VIRTUAL 2022 Investor Conference

Presentation to be Broadcast Wednesday December 7 at 3:30 p.m. EST/12:30 p.m.

Read More

InvestorPlace

May 9, 2022

Short Squeeze Stocks: RDBX, MDVL and 3 Others Experts Think Are Ready to Pop

Short squeeze stocks are in focus today following another bearish week for the markets. Here are Fintel's top short squeeze candidates.

Read More

PennyStocks

May 5, 2022

Trending Penny Stocks to Watch As the First Week of May Ends

Are these trending penny stocks on your watchlist in May? The post Trending Penny Stocks to Watch As the First Week of May Ends  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

InvestorPlace

May 2, 2022

Short Squeeze Stocks: HCDI, ZYME and 3 Others Experts Think Are Ready to Pop

Short squeeze stocks are once again in focus this week as Fintel released its weekly Short Squeeze Leaderboard report. Let's take a look.

Read More

Benzinga

May 2, 2022

5 Short Squeeze Candidates To Watch This Week: Aterian, Harbor Custom Development Remain At The Top, Veru Joins

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

Read More
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep